ArticleBlood neoplasia2026

Validation of ELN 2024 genetic classification in patients with AML treated with HMA-based regimens: PETHEMA registry study.

Eva Barragán et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.